← Open Payments lookup

RAUL RAMIREZ: Open Payments

NPI 1053459750 · KYLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$393 in 22 payments from 12 companies in 2025. Trend: 2023 $17 · 2024 $54 · 2025 $393

Food & beverage: $393
CompanyPaymentsAmount
Lilly USA, LLC10$171
Novo Nordisk Inc2$49
RECORDATI_RARE_DISEASES_INC.1$23
Biogen, Inc.1$21
Phathom Pharmaceuticals, Inc.1$19
AstraZeneca Pharmaceuticals LP1$18
Takeda Pharmaceuticals U.S.A., Inc.1$17
Abbott Laboratories1$17
Amgen Inc.1$15
Antares Pharma, Inc.1$14

Products named: MOUNJARO, ZEPBOUND, KISUNLA, Ozempic, ISTURISA, LEQEMBI, VOQUEZNA, TRINTELLIX.

Industry payments across TX — which companies pay providers there.